MRNA•Nasdaq said Moderna will replace Warner Bros. Discovery on the Nasdaq 100 effective October 9. Moderna shares have risen more than sixfold this year, giving it a valuation of roughly $75 billion.
Nasdaq said vaccine maker Moderna will replace Warner Bros. Discovery on the Nasdaq 100 effective October 9. Moderna shares have risen more than sixfold this year to a valuation of roughly $75 billion.
Warner Bros. Discovery is also set to be removed from indexes of major providers such as MSCI and S&P as its merger with Paramount Skydance is expected to close October 6, following a months-long holdup.
